Equity Capital Markets

Protagonist Therapeutics, Inc.

04/23
|
$100.0 Million
Protagonist
Piper Sandler served as bookrunner for Protagonist Therapeutics, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sector
Healthcare
Sub-Sector
Biopharma

Related Transactions

All Transactions
$250.3 Million
Natera
Natera, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$138.0 Million
Arhaus
Arhaus, LLC
Follow-On Offering
Active Bookrunner
$57.0 Million
Gladstone
Gladstone Capital Corporation
Senior Notes Offering
Left Bookrunner
$149.9 Million
Procept
Procept Biorobotics Corp.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$60.0 Million
Inozyme
Inozyme Pharma, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$80.0 Million
Turnstone
Turnstone Biologics Inc.
Initial Public Offering
Active Bookrunner
$85.0 Million
Sagimet
Sagimet Biosciences
Initial Public Offering
Active Bookrunner
$75.0 Million
BlackDiamond
Black Diamond Therapeutics
Confidentially Marketed Follow-On Offering
Left Bookrunner
$461.4 Million
Savers
Savers, Inc.
Initial Public Offering
Passive Bookrunner
$67.9 Million
praxis
Praxis Precision Medicines
Confidentially Marketed Follow-On Offering
Active Bookrunner
$365.4 Million
cava
Cava Group, Inc.
Initial Public Offering
Active Bookrunner
$103.5 Million
BlueBird
Blue Bird Corporation
Follow-On Offering
Passive Bookrunner
$1.2 Billion
Corebridge
Corebridge Financial, Inc
Follow-On Offering
Active Bookrunner
$50.0 Million
Akoya
Akoya Biosciences, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$150.0 Million
Cogent
Cogent Biosciences
Confidentially Marketed Follow-On Offering
Active Bookrunner
$101.8 Million
SkywardSpecialty
Skyward Specialty Insurance
Follow-On Offering
Passive Bookrunner

© 2023 Piper Sandler Companies. Since 1895. All rights reserved.